• JC-1 Mitochondrial Membrane Potential Assay Kit: Protocols &

  2026-05-24

  The JC-1 Mitochondrial Membrane Potential Assay Kit empowers researchers to quantify mitochondrial health and apoptosis dynamics with ratiometric precision. Discover advanced workflow strategies, troubleshooting insights, and how recent immunomodulatory breakthroughs shape practical assay design.

• Lyso-Tracker Red: Precision Lysosome Labeling in Live Cells

  2026-05-23

  Lyso-Tracker Red is a high-specificity fluorescent lysosome probe for live cell imaging, enabling robust visualization of intracellular acidic compartments. Its selective accumulation and red fluorescence support advanced analysis of lysosomal distribution and function. The probe is supplied by APExBIO and is a benchmark reagent in cell biology research.

• Myriocin in Sphingolipid Metabolism: Beyond Inhibition to Ce

  2026-05-22

  Explore how Myriocin, a potent serine palmitoyltransferase inhibitor, advances sphingolipid metabolism research and cell cycle regulation. This article uniquely bridges mechanistic insights with emerging mitochondrial and cellular aging paradigms.

• Curcumol Drives Necroptosis in Hepatic Stellate Cells via KA

  2026-05-22

  This study uncovers how Curcumol targets the KAT8–HK2–lactylation pathway to induce necroptosis in hepatic stellate cells, thereby reducing liver fibrosis. These findings highlight a novel metabolic vulnerability for therapeutic intervention in fibrotic liver disease.

• Metabolomics Distinguishes Carbapenemase-Producing Enterobac

  2026-05-21

  This study leverages LC-MS/MS metabolomics to rapidly differentiate carbapenemase-producing Enterobacterales from non-resistant strains based on distinct metabolic signatures. The findings highlight a panel of metabolic biomarkers and pathway disruptions, offering a foundation for faster diagnostics and deeper mechanistic insight into antibiotic resistance.

• Coronavirus Macrodomains Counteract PARP-Mediated Antiviral

  2026-05-21

  Grunewald et al. (2019) reveal that the coronavirus macrodomain is essential for evading host poly(ADP-ribose) polymerase (PARP)-mediated inhibition of viral replication and for modulating interferon responses. This study identifies PARP12 and PARP14 as key antiviral effectors, highlighting new mechanistic insights into virus-host interactions and suggesting potential targets for antiviral strategies.

• Perospirone Inhibits Vascular Kv1.5 Channels: Cardiovascular

  2026-05-20

  A recent study identifies perospirone, an atypical antipsychotic, as a direct inhibitor of vascular Kv1.5 channels in coronary arterial smooth muscle cells. This finding extends the pharmacological understanding of perospirone beyond its classical receptor targets and highlights potential cardiovascular considerations relevant for translational research.

• Phillygenin Alleviates Diabetic Nephropathy via TLR4 and PI3

  2026-05-20

  The referenced study demonstrates that phillygenin, a Forsythia suspensa derivative, reduces inflammation and apoptosis in diabetic nephropathy by targeting TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β pathways. These findings provide mechanistic insight into phillygenin’s renoprotective effects and suggest new directions for therapeutic intervention in diabetic kidney disease.

• DAPI (hydrochloride): DNA Visualization in Histochemistry &

  2026-05-19

  DAPI (hydrochloride) is a DNA-specific fluorescent probe optimized for chromosome staining, DNA visualization in histochemistry, and cell cycle analysis. Its robust minor groove DNA binding and high fluorescence yield make it a benchmark reagent for fixed and live cell protocols.

• Indazole/Indole Glucagon Receptor Antagonists: SAR and Synth

  2026-05-19

  This study reports the discovery and structure–activity relationship (SAR) analysis of a novel series of indazole- and indole-based glucagon receptor antagonists, targeting hepatic glucose production for type 2 diabetes management. The authors detail efficient synthetic routes and demonstrate potent in vitro and in vivo activity, offering new leads for metabolic disease therapy.

• O-GlcNAcylation Regulates Wnt-Mediated Bone Formation via Gl

  2026-05-18

  This study reveals that O-GlcNAcylation is indispensable for Wnt-driven osteogenesis, mechanistically linking Wnt signaling to aerobic glycolysis and bone anabolism. These findings clarify the metabolic regulation underlying bone formation and provide new directions for osteoporosis research.

• Ibrexafungerp (MK 3118): Advanced Antifungal Workflows & Pro

  2026-05-18

  Ibrexafungerp (MK 3118) redefines antifungal research, uniquely maintaining potency against resistant Candida species at acidic pH—crucial for vulvovaginal candidiasis workflows. This guide delivers actionable protocols, troubleshooting, and data-driven insights for maximizing experimental and translational impact.

• Nanoparticle-Mediated PTEN mRNA Delivery Reverses Trastuzuma

  2026-05-17

  Dong et al. (2022) present a nanoparticle system for systemic delivery of PTEN mRNA, enabling restoration of tumor suppressor function and reversal of trastuzumab resistance in HER2-positive breast cancer. This work demonstrates that targeted mRNA delivery can inhibit the PI3K/Akt pathway, offering a mechanistically grounded approach to overcoming therapeutic resistance.

• Prenatal Esketamine Exposure Impairs Neurogenesis in Rats

  2026-05-16

  This study demonstrates that prenatal administration of esketamine in rats leads to lasting neurobehavioral deficits in offspring, linked to reduced neural proliferation and impaired hippocampal development. The work leverages 5-Ethynyl-2'-deoxyuridine (5-EdU) assays, highlighting their value in developmental neurotoxicity research.

• Ampicillin Sodium: Mechanistic Power for Translational Impac

  2026-05-15

  This thought-leadership article examines the scientific and strategic value of Ampicillin sodium as a β-lactam antibiotic in translational research. Through mechanistic insight, evidence from landmark studies, and protocol guidance, we map its critical role in antibacterial activity assays, protein production, and infection models—framing new opportunities for translational researchers to accelerate discovery and address antibiotic resistance.

15262 records 1/1018 page Next 12345 下5页 Last page